Loading...
Taxonomy, Diversity and Cultivation of the Oudemansielloid/Xeruloid Taxa Hymenopellis, Mucidula, Oudemansiella, and Xerula and with Respect to Their Bioactivities: A Review.
Niego, Allen Grace Raspé, Olivier Thongklang, Naritsada Charoensup, Rawiwan Lumyong, Saisamorn Stadler, Marc Hyde, Kevin D
Niego, Allen Grace
Raspé, Olivier
Thongklang, Naritsada
Charoensup, Rawiwan
Lumyong, Saisamorn
Stadler, Marc
Hyde, Kevin D
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2021-01-13
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 4.47 MB
Other Titles
Abstract
The oudemansielloid/xeruloid taxa Hymenopellis, Mucidula, Oudemansiella, and Xerula are genera of Basidiomycota that constitute an important resource of bioactive compounds. Numerous studies have shown antimicrobial, anti-oxidative, anti-cancer, anti-inflammatory and other bioactivities of their extracts. The bioactive principles can be divided into two major groups: (a) hydrophilic polysaccharides with relatively high molecular weights and (b) low molecular medium polar secondary metabolites, such as the antifungal strobilurins. In this review, we summarize the state of the art on biodiversity, cultivation of the fungi and bioactivities of their secondary metabolites and discuss future applications. Although the strobilurins are well-documented, with commercial applications as agrochemical fungicides, there are also other known compounds from this group that have not yet been well-studied. Polysaccharides, dihydro-citrinone phenol A acid, scalusamides, and acetylenic lactones such as xerulin, also have potential applications in the nutraceutical, pharmaceutical and medicinal market and should be further explored. Further studies are recommended to isolate high quality bioactive compounds and fully understand their modes of action. Given that only few species of oudemansielloid/xeruloid mushrooms have been explored for their production of secondary metabolites, these taxa represent unexplored sources of potentially useful and novel bioactive metabolites.
Citation
J Fungi (Basel). 2021 Jan 13;7(1):51. doi: 10.3390/jof7010051.
Publisher
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Review
Language
en
Description
Series/Report no.
ISSN
EISSN
2309-608X
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution 4.0 International